March 26, 2015 by Dan • Commentary

One of the great market mysteries of the last six months has been the lack of equity volatility during an endless march to new high after new high. That’s been despite a backdrop of crashing commodity …

Continue reading
March 10, 2015 by Dan • Commentary

The Biotech sector has been a massive out-performer over the last year, with the IBB (iShares Nasdaq Biotech etf) up 13% in 2015, and up 65% since from the 52 week lows made in April of last …

Continue reading
July 15, 2014 by Enis • Commentary

Back in March the biotechnology sector was hard hit hard alongside social media, solar and 3d printing. Since then, most of these sectors have recovered most of their losses from that sell-off. Which brings us …

Continue reading
June 12, 2014 by Enis • Commentary

Biotechs have been a leader throughout the 2009-2014 bull market.  The weekly chart of IBB, the biotech ETF, illustrates the incredible run over the past 5 years: The ETF more than quadrupled from early 2009 …

Continue reading